Literature DB >> 15284074

Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II.

Ning Lu1, Bryan G Helwig, Richard J Fels, Sujatha Parimi, Michael J Kenney.   

Abstract

In the present study, we established dose-response relationships between central administration of 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (Tempol, a superoxide dismutase mimetic) and the level of renal sympathetic nerve discharge (SND) and tested the hypothesis that intracerebroventricular (icv) Tempol pretreatment would attenuate centrally mediated changes in SND produced by icv ANG II administration. Urethane-chloralose-anesthetized, baroreceptor-denervated, normotensive rats were used. We found that icv Tempol administration produced dose-dependent sympathoinhibitory, hypotensive, and bradycardic responses. Mean arterial pressure and SND values were significantly increased after icv ANG II (150 ng/kg) administration, and these responses were abrogated after icv pretreatment with Tempol (75 micromol/kg) or losartan. Brain superoxide levels tended to be higher in ANG II-treated rats compared with rats treated with Tempol and ANG II. Tempol pretreatment did not prevent increases in SND level that were produced by acute heat stress, which indicates specificity in the effect of Tempol in reducing sympathoexcitation. These results demonstrate that icv Tempol administration influences central sympathetic neural circuits in a dose-dependent manner and attenuates SND responses to central ANG II infusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284074     DOI: 10.1152/ajpheart.00030.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  14 in total

1.  Intracerebroventricular tempol administration in older rats reduces oxidative stress in the hypothalamus but does not change STAT3 signalling or SIRT1/AMPK pathway.

Authors:  Hale Z Toklu; Philip J Scarpace; Yasemin Sakarya; Nataliya Kirichenko; Michael Matheny; Erin B Bruce; Christy S Carter; Drake Morgan; Nihal Tümer
Journal:  Appl Physiol Nutr Metab       Date:  2016-10-06       Impact factor: 2.665

Review 2.  Reactive oxygen species in the neuropathogenesis of hypertension.

Authors:  Jeffrey R Peterson; Ram V Sharma; Robin L Davisson
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

3.  In vivo bioluminescence imaging reveals redox-regulated activator protein-1 activation in paraventricular nucleus of mice with renovascular hypertension.

Authors:  Melissa A Burmeister; Colin N Young; Valdir A Braga; Scott D Butler; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

4.  Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats.

Authors:  Juan Gao; Hao Zhang; Khang D Le; Jie Chao; Lie Gao
Journal:  Am J Hypertens       Date:  2011-03-10       Impact factor: 2.689

Review 5.  Angiotensin II, sympathetic nerve activity and chronic heart failure.

Authors:  Yutang Wang; Sai-Wang Seto; Jonathan Golledge
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

6.  Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current.

Authors:  Jing-Xiang Yin; Rui-Fang Yang; Shumin Li; Alex O Renshaw; Yu-Long Li; Harold D Schultz; Matthew C Zimmerman
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-20       Impact factor: 4.249

7.  Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species.

Authors:  Baojian Xue; Yuanzi Zhao; Alan Kim Johnson; Meredith Hay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-03       Impact factor: 4.733

Review 8.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

9.  Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction.

Authors:  Timothy E Lindley; David W Infanger; Mark Rishniw; Yi Zhou; Marc F Doobay; Ram V Sharma; Robin L Davisson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-29       Impact factor: 3.619

Review 10.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.